Overview of COVID-19-associated invasive fungal infection
AA Shishido, M Mathew, JW Baddley - Current Fungal Infection Reports, 2022 - Springer
Abstract Purpose of Review Invasive fungal infections are a complication of COVID-19
disease. This article reviews literature characterizing invasive fungal infections associated …
disease. This article reviews literature characterizing invasive fungal infections associated …
Fungal infections other than invasive aspergillosis in COVID-19 patients
K Basile, C Halliday, J Kok, SCA Chen - Journal of Fungi, 2022 - mdpi.com
Invasive fungal disease (IFD) associated with Coronavirus Disease 2019 (COVID-19) has
focussed predominantly on invasive pulmonary aspergillosis. However, increasingly …
focussed predominantly on invasive pulmonary aspergillosis. However, increasingly …
Post-COVID-19 fungal infection in the aged population
Coronavirus disease 2019 (COVID-19) infection is currently a great cause of concern for the
healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious …
healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious …
[HTML][HTML] Invasive respiratory fungal infections in COVID-19 critically ill patients
F Raffaelli, ES Tanzarella, G De Pascale… - Journal of Fungi, 2022 - mdpi.com
Patients with coronavirus disease 19 (COVID-19) admitted to the intensive care unit (ICU)
often develop respiratory fungal infections. The most frequent diseases are the COVID-19 …
often develop respiratory fungal infections. The most frequent diseases are the COVID-19 …
A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients
Introduction Pneumocystis jirovecii is an opportunistic, human-specific fungus that causes
Pneumocystis pneumonia (PCP). PCP symptoms are nonspecific. A patient with P. jirovecii …
Pneumocystis pneumonia (PCP). PCP symptoms are nonspecific. A patient with P. jirovecii …
Pneumocystis pneumonia in COVID-19 patients: A comprehensive review
The admitted patients of intensive care units with coronavirus disease 2019 (COVID-19)
meet the challenges of subsequent infections. Opportunistic fungal infections such as …
meet the challenges of subsequent infections. Opportunistic fungal infections such as …
Imaging of pulmonary superinfections and co-infections in COVID-19
P Naranje, AS Bhalla, M Jana, M Garg, AD Nair… - Current Problems in …, 2022 - Elsevier
New challenges in imaging and management of COVID-19 pneumonia emerge as the
pandemic continues across the globe. These arise not only due to the COVID-19 pneumonia …
pandemic continues across the globe. These arise not only due to the COVID-19 pneumonia …
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls
PL White - Current Opinion in Infectious Diseases, 2021 - journals.lww.com
Because of the vast numbers of COVID-19 infections, IFD in COVID-19 critical-care patients
represents a significant burden of disease, even if incidences are less than 5%. Optimal …
represents a significant burden of disease, even if incidences are less than 5%. Optimal …
Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
F Gioia, H Albasata, SM Hosseini-Moghaddam - Journal of Fungi, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) may occur with concurrent infections caused by
bacterial and fungal microorganisms. This systematic review evaluated studies reporting …
bacterial and fungal microorganisms. This systematic review evaluated studies reporting …
Pneumocystis jirovecii Infections Among COVID-19 Patients: A Case Series and Literature Review
P Amstutz, NC Bahr, K Snyder… - Open Forum Infectious …, 2023 - academic.oup.com
Background Pneumocystis jirovecii pneumonia (PCP) is a serious, emerging complication of
coronavirus disease 2019 (COVID-19). Methods We performed a systematic review of …
coronavirus disease 2019 (COVID-19). Methods We performed a systematic review of …